<html>
	<head>
		<title>pfizer <pfe> studies drug as weight loss tool</title>
		<meta name="keywords" content="places usa">
</head>
<body>
	<h3>pfizer inc said it expects to file a new drug application in the u.s. and in other markets this year for sertraline, a treatment for depression.     in its annual report, pfizer said that in addition to the drug's anti-depressant action, sertraline is currently undergoing studies to explore its ability to promote weight loss. company officials were not immediately available to comment further.     eli lilly and co's <lly> prozac, an antidepressant awaiting marketing approval, has shown promise in promoting weight loss.     pfizer also said it plans to file for u.s. marketing approval for certrizine, a "novel" antihistamine for hay fever, and other allergic reactions.     in 1986, pfizer earned 660 mln dlrs or 3.90 dlrs per share on revenues of 4.5 billion dlrs.  reuter &#3;</h3>
</body>
</html>